The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
Open accessAbstract
Fungal pathogens form biofilms that are highly recalcitrant to antimicrobial therapy. The expression of multidrug resistance pumps in young biofilms has been linked to increased resistance to azoles, but this mechanism does not seem to underlie the resistance of mature biofilms that is a model of in vivo infection. The mechanism of drug resistance of mature biofilms remains largely unknown. We report that biofilms formed by the major human pathogen Candida albicans exhibited a strikingly biphasic killing pattern in response to two microbicidal agents, amphotericin B, a polyene antifungal, and chlorhexidine, an antiseptic, indicating that a subpopulation of highly tolerant cells, termed persisters, existed. The extent of killing with a combination of amphotericin B and chlorhexidine was similar to that observed with individually added antimicrobials. Thus, surviving persisters form a multidrug-tolerant subpopulation. Interestingly, surviving C. albicans persisters were detected only in biofilms and not in exponentially growing or stationary-phase planktonic populations. Reinoculation of cells that survived killing of the biofilm by amphotericin B produced a new biofilm with a new subpopulation of persisters. This suggests that C. albicans persisters are not mutants but phenotypic variants of the wild type. Using a stain for dead cells, rare dark cells were visible in a biofilm after amphotericin B treatment, and a bright and a dim population were physically sorted from this biofilm. Only the dim cells produced colonies, showing that this method allows the isolation of yeast persisters. Given that persisters formed only in biofilms, mutants defective in biofilm formation were examined for tolerance of amphotericin B. All of the known mutants affected in biofilm formation were able to produce normal levels of persisters. This finding indicates that attachment rather than formation of a complex biofilm architecture initiates persister formation. Bacteria produce multidrug-tolerant persister cells in both planktonic and biofilm populations, and it appears that yeasts and bacteria have evolved analogous strategies that assign the function of survival to a small part of the population. In bacteria, persisters are dormant cells. It remains to be seen whether attachment initiates dormancy that leads to the formation of fungal persisters. This study suggests that persisters may be largely responsible for the multidrug tolerance of fungal biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, antifungal persistence is mainly identified in Candida-associated biofilms [2,32,33].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antifungal persistence is most commonly observed in biofilm rather than in planktonic cells [2,33,34]”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To solve these problems, live/dead staining method can be applied because of its ability to distinguish live/dead cells, which reflects the essence of persisters that survive exposure to fungicides.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“For example, C. albicans persister biofilms are recalcitrant to AmB and broad-spectrum antimicrobial agent chlorhexidine [2];”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“indicating that antifungal persistence is not solely dependent on matured biofilm structure formation [2].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“However, LaFleur and colleagues first reported that the biofilm-deficient double mutant strain efg1Δ/cph1Δ did not result in the reduction of AmB-triggered persisters”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
In the citing paper
“Inside the biofilm cell population, persister cells form a unique group that is formed randomly, phenotypically dormant, highly tolerant to antifungal drugs [164], and which is a key mechanism of resistance in chronic infections [130].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [164]
In the citing paper
“A minor subset of metabolically dormant yeast cells that stochastically arise as phenotypical variants within biofilms, persister cells are extremely resistant to antifungal drugs (100).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [100]
In the citing paper
“Although we know little about the formation and roles of persister cells in C. albicans biofilms, we do know that the drug resistance of persister cells is independent of cell membrane composition and efflux pump expression; rather, it is the result of the metabolically dormant state of the cells (88, 100).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A. L., Wang, Y., & Lewis, K. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,094
Self-citationCandida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 907
Self-citationSpecialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A. L., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 848
Self-citationKuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1111/j.1574-6968.2002.tb11330.x · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 519
de Moraes, D. C. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101232 · Cited by 16
Ferrisse, T. M., Dias, L. M., de Oliveira, A. B., Jordão, C. C., Mima, E. G. D. O., & Pavarina, A. C. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102876 · Cited by 14
Microbial persisters and host: recent advances and future perspectives
Wang, C., & Jin, L. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2125286 · Cited by 14
Exploration of the anticandidal mechanism of Cassia spectabilis in debilitating candidiasis
Torey, A., Vijayarathna, S., Jothy, S. L., Gothai, S., Chen, Y., Latha, L. Y., Kanwar, J. R., Dharmaraj, S., & Sasidharan, S. (2015) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2014.11.017 · Cited by 14
In vitro effectiveness of Anidulafungin against Candida sp. biofilms
Rosato, A., Piarulli, M., Schiavone, B. I. P., Catalano, A. A., Carocci, A., Carrieri, A., Carone, A., Caggiano, G., Franchini, C., Corbo, F., et al. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.83 · Cited by 14
Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms
Brucker, K. D., Cremer, K. D., Cammue, B. P. A., & Thevissen, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2854-5_6 · Cited by 15
Li, P., Seneviratne, C. J., Luan, Q., & Jin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.639123 · Cited by 13
Endurance of extremely prolonged nutrient prevention across kingdoms of life
Hazan, R., Schoemann, M., & Klutstein, M. (2021) · iScience · doi:10.1016/j.isci.2021.102745 · Cited by 14
Candida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
Dominguez, E. G., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_6 · Cited by 14
Kampf, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-98785-9_13 · Cited by 13
Krumina, G., Ratkevicha, L., Nikolajeva, V., Babarikina, A., & Babarykin, D. A. (2015) · Proceedings of the Estonian Academy of Sciences · doi:10.3176/proc.2015.1.08 · Cited by 13
Harriott, M. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62124-4 · Cited by 14
Tolerance to antimicrobial agents and persistence of Escherichia coli and cyanobacteria
Samuilov, V. D., Bulakhov, A. V., Kiselevsky, D. B., Kuznetsova, Y. E., Molchanova, D. V., Sinitsyn, S. V., & Shestak, A. A. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908070122 · Cited by 13
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12
Efflux systems driving resistance and virulence across biological domains
da Silva, P. E. A., von Groll, A., Ramis, I. B., Reis, A. J., Ramos, D. F., & Viveiros, M. (2025) · PeerJ · doi:10.7717/peerj.20360 · Cited by 12
Sahoo, B., Goyal, R., Dutta, S., Joshi, P., & Sanyal, K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00079 · Cited by 13
Rebelo, J. S., Domingues, C. P. F., Monteiro, F., Nogueira, T., & Dionísio, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246500 · Cited by 13
Al-Madboly, L. A., El-Salam, M. A. A., Bastos, J. K., El-Shorbagy, S. H., & El-Morsi, R. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02724-21 · Cited by 12
Glucose modulates antimicrobial photodynamic inactivation of Candida albicans in biofilms
Suzuki, L. C., Kato, I. T., Prates, R. A., Sabino, C. P., Yoshimura, T. M., de Oliveira-Silva, T., & Ribeiro, M. S. (2016) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2016.12.003 · Cited by 12
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 12
Lavaee, F., Badiei, P., Yousefi, M., & Haddadi, P. (2021) · Current Medical Mycology · doi:10.18502/cmm.6.4.5332 · Cited by 12
Ashraf, A., Yousri, F., Taha, N., El-Waly, O. A., Ramadan, A. E.-K., Ismail, E., Hamada, R., Khalaf, M., Refaee, M., Ali, S. S., et al. (2015) · American journal of microbiological research · doi:10.12691/ajmr-3-1-1 · Cited by 12
Squitieri, D., Rizzo, S., Torelli, R., Mariotti, M., Sanguinetti, M., Cacaci, M., & Bugli, F. (2025) · Pharmaceuticals · doi:10.3390/ph19010008 · Cited by 12
Identification of effective plant extracts against candidiasis: an in silico and in vitro approach
Bhairavi, V. A., Vidya, S. L., & Sathishkumar, R. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00489-x · Cited by 11
Kumar, D., & Kumar, A. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2022.0347 · Cited by 11
Aboualigalehdari, E., Tahmasebi Birgani, M., Fatahinia, M., & Hosseinzadeh, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651221 · Cited by 11
Häring, M., Amann, V., Kissmann, A., Herberger, T., Synatschke, C. V., Kirsch-Pietz, N., Perez‐Erviti, J. A., Otero‐González, A. J., Morales-Vicente, F., Andersson, J., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071332 · Cited by 12
Characterization of Pleurotus ostreatus Biofilms by Using the Calgary Biofilm Device
Pesciaroli, L., Petruccioli, M., Fedi, S., Firrincieli, A., Federici, F., & D’Annibale, A. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02099-13 · Cited by 11
Foglia, F., Rogers, S. E., Webster, J. R. P., Akeroyd, F., Gascoyne, K. F., Lawrence, M. J., & Barlow, D. J. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01365 · Cited by 12
Exopolysaccharides and Biofilms
Mauff, F. L. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_199 · Cited by 13
Quantification methods of Candida albicans are independent irrespective of fungal morphology
Soares, A. B., de Albuquerque, M. C., Rosa, L. M., Klein, M. I., Pavarina, A. C., Barbugli, P. A., Dovigo, L. N., & Mima, E. G. D. O. (2024) · Microbial Cell · doi:10.15698/mic2024.07.831 · Cited by 10
Mashaly, G. E.-S., & Zeid, M. S. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s344998 · Cited by 10
Tolerance and Persister Formation in Oral Streptococci
Suppiger, S., Astasov‐Frauenhoffer, M., Schweizer, I., Waltimo, T. M. T., & Kulik, E. M. (2020) · Antibiotics · doi:10.3390/antibiotics9040167 · Cited by 10
Hernández-Benítez, J. A., Santos-Ocampo, B. N., Rosas–Ramírez, D., Ramírez‐Granillo, A., Bautista-Hernández, L. A., Pérez, N. O., Pérez, N. O., & Rodríguez-Tovar, A. V. (2025) · Journal of Fungi · doi:10.3390/jof11010053 · Cited by 9
Persister cells in human fungal pathogens
Xie, Y., Ke, W., Wong, K. H., & Wang, L. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013483 · Cited by 10
Martínez, J. P., Blanes, R., Casanova, M., Valentı́n, E., Murgui, A., & Domínguez, Á. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow075 · Cited by 10
Effect of surface treatments of titanium on amphotericin B-treated Candida albicans persister cells
Tsang, C. S. P., & Tang, D. Y. K. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01790.x · Cited by 9
Lagree, K., & Mitchell, A. P. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch42 · Cited by 9
Drug Repurposing Strategy against Fungal Biofilms
de Mello, T. P., Silva, L. N., Ramos, L. S., Frota, H. F., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662007200316142626 · Cited by 9
Lakins, M. A., Marrison, J., O’Toole, P. J., & van der Woude, M. W. (2009) · Journal of Microscopy · doi:10.1111/j.1365-2818.2009.03190.x · Cited by 9
Ultrasound-assisted treatment of sternocutaneous fistula in post-sternotomy cardiac surgery patients
Tewarie, L., Moza, A. K., Zayat, R., Autschbach, R., Goetzenich, A., & Menon, A. K. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv007 · Cited by 8
The Functional Resistance of Biofilms
Manavathu, E. K., & Vázquez, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_11 · Cited by 9
Update on the Fungal Biofilm Drug Resistance and Its Alternative Treatment
Tseung, K. S. Y. N. H., & Zhao, J. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.45004 · Cited by 8
Biofilm Formation byCryptococcus neoformans
Martinez, L. R., & Casadevall, A. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch7 · Cited by 8
Role of Microbial Communities in Sustainable Rice Cultivation
Perera, T. A., & Tirimanne, S. (2021) · Microorganisms for sustainability · doi:10.1007/978-981-15-9912-5_7 · Cited by 8
Sinoca, M., Maione, A., Gambino, E., Imparato, M., Galdiero, M., de Alteriis, E., Galdiero, E., & Guida, M. (2024) · Biomedicines · doi:10.3390/biomedicines12020389 · Cited by 7
Flow cytometry-based method to detect persisters in Candida albicans
Chang, W., Zhang, M., Li, Y., & Lou, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00255-15 · Cited by 7
Antifungal Efficacy of Terpenes and Mechanism of Action Against Human Pathogenic Fungi
Raj, N., Parveen, P., Khatoon, S., & Manzoor, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_11 · Cited by 7
Polymicrobial biofilms: biological insights and emerging directions in drug discovery
Arasu, A. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2604691 · Cited by 8
The pathogenicity and future treatment strategies of Candida albicans
Wu, J., Jiang, C., Wang, H., Chen, T., Chen, X., & Da, W. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1752304 · Cited by 7
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
Debta, P., Sahu, B. K., Patra, S. K., Debta, F. M., Mishra, E., & Panda, S. K. (2026) · Frontiers in Antibiotics · doi:10.3389/frabi.2026.1767028 · Cited by 8
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 7
Fairlamb, A. H., & Cole, S. T. (2011) · Future Microbiology · doi:10.2217/fmb.11.54 · Cited by 7
Candida albicans Biofilm Development and Its Genetic Control
Desai, J. V., & Mitchell, A. P. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch5 · Cited by 8
Functional analysis of selected deletion mutants in Candida glabrata under hypoxia
Gupta, P., Meena, R. C., & Kumar, N. (2017) · 3 Biotech · doi:10.1007/s13205-017-0821-7 · Cited by 8
Oral and Maxillofacial Fungal Infections
Manfredi, M., Polonelli, L., Giovati, L., Alnuaimi, A., & McCullough, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_1 · Cited by 7
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch19 · Cited by 7
Rifampicin induced virulence determinants increase Candida albicans biofilm formation
Vogel, M., Köberle, M., Schäffler, H., Treiber, M. K., Autenrieth, I. B., & Schumacher, U. (2013) · F1000Research · doi:10.12688/f1000research.2-106.v1 · Cited by 7
Sun, J., Liu, X., Jiang, G., & Qi, Q. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03765-14 · Cited by 6
The Extracellular Matrix of Yeasts: A Key Player in the Microbial Biology Change of Paradigm
Lucas, C., & da Silva, C. F. (2023) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1502013 · Cited by 6
Sadanandan, B., Vijayalakshmi, V., Shetty, K., Rathish, A., Shivkumar, H., Gundreddy, M., Narendra, N. K. K., & Devaiah, N. M. (2025) · Gels · doi:10.3390/gels11010023 · Cited by 6
Machineni, L., Reddy, C. T., Nandamuri, V., & Pawar, P. D. (2018) · Mathematical Methods in the Applied Sciences · doi:10.1002/mma.4900 · Cited by 6
D’Agostino, M., Tesse, N., Lavergne, R., Pape, P. L., Frippiat, J., Machouart, M., & Debourgogne, A. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001399 · Cited by 6
Aguiar, A. L. R., da Silva, B. N., Fiallos, N. D. M., Pereira, L. M. G., Silva, M. L., de Souza, P. D. F. S. M., Portela, F. V. M., Sidrim, J. J. C., Rocha, M. F. G., Castelo‐Branco, D. D. S. C. M., et al. (2023) · Biofouling · doi:10.1080/08927014.2023.2202315 · Cited by 6
Candida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
LaFleur, M. D. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010021 · Cited by 6
Self-citationThe Influence of Cellulose-Type Formulants on Anti-Candida Activity of the Tyrocidines
Masoudi, Y., van Rensburg, W., Barnard-Jenkins, B., & Rautenbach, M. (2021) · Antibiotics · doi:10.3390/antibiotics10050597 · Cited by 6
Fungal Biofilms:In VivoModels for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch2 · Cited by 6
Microbial dormancy and prevention of healthcare-associated infections
Tutelyan, A. V., Михайлович, Г. А., Писарев, В. М., & El-Registan, G. I. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh20158711103-109 · Cited by 6
Mucosal Immunity toCandida albicans
Fidel, P. L., & Noverr, M. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch10 · Cited by 6
Biofilm Resistance–Tolerance to Conventional Antimicrobial Agents
(2010) · Wiley eBooks · doi:10.1002/9780470640463.ch4 · Cited by 6
A novel approach: targeting virulence factors of Candida albicans with essential oil components
Shaban, A. M. A., & Darmani, H. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae012 · Cited by 5
Gaitán, A. C. R., & del Pozo, J. L. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.03.004 · Cited by 6
Nature-derived gelatin-based antifungal nanotherapeutics for combatting Candida albicans biofilms
Nabawy, A. M., Makabenta, J. M., Park, J., Huang, R., Nayar, V., Patel, R., & Rotello, V. M. (2023) · Environmental Science Nano · doi:10.1039/d3en00372h · Cited by 5
Silva, S. D. M., Echeverri, C. R., Mendes‐Giannini, M. J. S., Fusco‐Almeida, A. M., & González, Á. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100246 · Cited by 5
Antifungal effect of plant extracts on Candida albicans biofilm on acrylic resin
de Oliveira, J. R., Vilela, P. D. G. F., de Oliveira, F. E., Belato, K. K., Carvalho, C. A. T., Jorge, A. O. C., & de Oliveira, L. D. (2013) · Brazilian Dental Science · doi:10.14295/bds.2013.v16i3.909 · Cited by 5
Polymicrobial biofilms: Impact on fungal pathogenesis
Costa-Orlandi, C. B., Bila, N. M., Vaso, C. O., Pires, A. C. M. D. S., Silva, S. D. M., Medina‐Alarcón, K. P., Marcos, C. M., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99977-9.00040-5 · Cited by 5
Zhu, W., & Guo, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1811011 · Cited by 5
Xu, X., Wu, X., Yuan, G., Xu, L., & Wang, Y. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.412020 · Cited by 4
Ye, M., Chen, H., Liu, C., Ren, A.-J., Yang, H., & Wang, S.-S. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15718 · Cited by 4
Chandley, P., Subba, P., & Rohatgi, S. (2022) · Journal of Visualized Experiments · doi:10.3791/64425 · Cited by 4
In Vivo Candida Device Biofilm Models
Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_7 · Cited by 4
Antisense mqsR-PNA as a putative target to the eradication of Pseudomonas aeruginosa persisters
Alhusseini, L. B., Maleki, A., & Marjani, M. F. A. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100868 · Cited by 5
Studying Bacterial Persistence: Established Methods and Current Advances
Louwagie, E., Verstraete, L., Michiels, J. J., & Verstraeten, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1621-5_1 · Cited by 4
Mukherjee, A., Saini, A., Kumari, A., Bhattacharya, J., Banerjee, A., Prasad, R., & Moulick, R. G. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101140 · Cited by 4
Eliminating Mycobacterial Persistence: Novel Targets for Anti-TB Therapy
Bhaskar, A., Dwivedi, V. P., & Nandicoori, V. K. (2019) · Springer eBooks · doi:10.1007/978-981-32-9449-3_3 · Cited by 4
Effect of Voriconazole on Biofilm of Filamentous Species Isolated from Keratitis
Fattahi, A., Ghasemi, R., Pinegina, O. N., Bahrami, M. M., Hosseini, M., & Lotfali, E. (2022) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid-122452 · Cited by 3
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 3
Superbugs, silver bullets, and new battlefields
Rashid, M. I., Tariq, P., Rashid, H., Ali, Z., Andleeb, S., Gul, A., Öztürk, M., & Altay, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819541-3.00006-2 · Cited by 3
Vancomycin enhances growth and virulence of Trichosporon spp. planktonic cells and biofilms
Cordeiro, R. D. A., da Silva, B. N., Aguiar, A. L. R., Pereira, L. M. G., Portela, F. V. M., da Rocha, M. G., Pergentino, M. L. M., Sales, G., de Sousa, J. K., Camargo, Z. P. D., et al. (2021) · Medical Mycology · doi:10.1093/mmy/myab001 · Cited by 3
Al-Rejaboo, M. A., Almola, Z. S., & Almashhadani, M. A. (2024) · Journal of Applied and Natural Science · doi:10.31018/jans.v16i4.5852 · Cited by 3
Biofilm Formation inCandida albicans
Finkel, J. S., & Mitchell, A. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch19 · Cited by 4
Host-Fungal Interactions: Pathogenicity versus Immunity
Tavanti, A., Naglik, J. R., & Osherov, N. (2012) · International Journal of Microbiology · doi:10.1155/2012/562480 · Cited by 4
Fungal Biofilms: Formation, Resistance and Pathogenicity
Sardi, J. D. C. O., de Souza, N., Gullo, F. P., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2015) · CRC Press eBooks · doi:10.1201/b18707-17 · Cited by 3
Yeast Infections After Solid Organ Transplantation
McCarty, T. P., & Pappas, P. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_38 · Cited by 3
The Role of Biofilm Matrix in Mediating Antifungal Resistance
Nett, J. E., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_20 · Cited by 3
Seneviratne, C. J., Srivastava, N., Islam, I., & Allen, P. (2017) · CRC Press eBooks · doi:10.4324/9781315120119-1 · Cited by 3
Isothermal Microcalorimetry for the Investigation of Clinical Samples: Past and Present
Braissant, O., Bonkat, G., & Bachmann, A. (2016) · CRC Press eBooks · doi:10.1201/b20161-24 · Cited by 3
Was bieten Candida‐Biofilme Besonderes? Something special of Candida biofilms?
Bernhardt, H., & Knoke, M. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01585.x · Cited by 3
Mechanisms of Stress‐Activated Persister Formation inEscherichia Coli
Amato, S. M., & Brynildsen, M. P. (2016) · Wiley eBooks · doi:10.1002/9781119004813.ch40 · Cited by 3
Luong, J. H. T., & Gedanken, A. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108994 · Cited by 2
Metadata
- Authors
- LaFleur, M. D., Kumamoto, C. A., & Lewis, K.
- Affiliations
- Northeastern University (US)
- Tufts University (US)
- Corresponding author
- Lewis, Kim
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 50
- Issue
- 11
- Pages
- 3839-3846
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1635216
- OpenAlex
- W2135493487
- Cited by
- 521
- References
- 52
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 20 · 2023: 20 · 2022: 20 · 2021: 39 · 2020: 33 · 2019: 21 · 2018: 22 · 2017: 41 · 2016: 34 · 2015: 39 · 2014: 25 · 2013: 31 · 2012: 26
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Tufts University School of Medicine
- National Institute of General Medical Sciences (R01GM061162)
- National Institute of Allergy and Infectious Diseases (AI052805, R01AI052805)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, persister cells, antifungal tolerance, multidrug tolerance, amphotericin B, chlorhexidine, phenotypic variants, biofilm formation, cell attachment, dormancy, antifungal resistance
- MeSH terms
- Antifungal Agents, Candida albicans, Chlorhexidine, Disinfectants, Fluoresceins, Microbial Sensitivity Tests, Microscopy, Fluorescence, Phenotype, Biofilms, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
